| Literature DB >> 30679658 |
Hye-Ryeon Heo1,2, Jeeyoung Kim1,2, Woo Jin Kim1,2, Se-Ran Yang3, Seon-Sook Han1, Seong Joon Lee1, Yoonki Hong4,5, Seok-Ho Hong6,7.
Abstract
Human pluripotent stem cell (hPSC)-derived alveolar epithelial cells (AECs) provide new opportunities for understanding lung development and the treatment of pulmonary diseases. However, toxicity assessments using hPSC-AECs have not been undertaken. In this study, we generated functional AECs from hPSCs and evaluated their inflammatory and apoptotic responses to cadmium (Cd) exposure (1, 5, and 10 μM) for 24 h compared with the human bronchial epithelial cell line (BEAS-2B) and primary AECs as controls. Our data showed that Cd (10 μM) treatment induced substantial inflammatory responses and apoptosis in BEAS-2B cells, but not in both hPSC-AECs and primary AECs. Interestingly, conditioned medium from AEC cultures significantly alleviated apoptotic and inflammatory responses to Cd exposure in BEAS-2B cells. Using cytokine arrays, several potential factors secreted from hPSC-AECs and primary AECs were detected and may be involved in reducing Cd-induced cytotoxicity. We also observed higher expression of surfactant proteins B and C in both hPSC-AECs and primary AECs, which may contribute to protection against Cd-induced cytotoxicity. These results suggested that hPSC-AECs phenotypically and functionally resemble primary AECs and could be more biologically relevant alternatives for evaluating the pathological contribution of confirmed or potential pulmotoxic materials included in smoking and microdust.Entities:
Year: 2019 PMID: 30679658 PMCID: PMC6346100 DOI: 10.1038/s41598-018-37193-3
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Generation and characterization of hiPSC-AECs. (a) Schematic diagram of stepwise AEC differentiation from hiPSCs based on lung developmental process. (b) Immunofluorescence staining for OCT4 (red) in feeder-free hiPSC cultures. Nuclei were counterstained with DAPI (blue). Scale bar: 100 μm. BF, bright field. (c) Representative images of AECs differentiated from hiPSCs. Scale bars: 500 μm. DEC, definitive endodermal cell; AFEC, anterior foregut endodermal cell. (d) Immunofluorescence staining for NKX2.1 (red or green), EPCAM (red) and CPM (red) in hiPSC-derived AECs on day 14 of differentiation. Scale bar: 100 μm. (e) Representative FACS plots based on expression of NKX2.1, EPCAM, CPM, STFPB and STFPC in hiPSC-AECs. Frequencies are shown in each plot. (f) TEM of day 14 hiPSC-AECs. Black arrowheads indicate lysosome (LY). White arrowheads indicate LBs. NU, nucleus. (g) Flow cytometry analysis of AEC1 and AEC2 marker expression in day 25 hiPSC-AECs. Error bars indicate SD.
Figure 2Comparison of the basal expression levels of inflammation- and apoptosis-related genes in BEAS-2B cells, hiPSC- and primary AECs. Quantitative real-time PCR analysis of inflammation and apoptosis-related gene expression in BEAS-2B cells, hiPSC- and primary AECs. Black dotted lines indicate transcript levels of genes in BEAS-2B cells. Error bars indicate SD. *p < 0.05, **p < 0.01 (BEAS-2B cells vs. hiPSC-AECs or primary AECs).
Figure 3Effects of Cd exposure on inflammation- and apoptosis-related gene expression in BEAS-2B cells, hiPSC- and primary AECs. (a) Morphological changes in BEAS-2B cells, hiPSC- and primary AECs after Cd treatment. All cells were cultured in the absence or presence (10 μM) of Cd for 24 h. Scale bar: 100 μm. (b,c) BEAS-2B cells and primary AECs were treated with the indicated concentrations of Cd for 24 h. On day 14 of differentiation, AECs were treated with the same Cd doses. Transcript levels of inflammation- (b) and apoptosis-related genes (c) were measured using quantitative real-time PCR. Black dotted line, BEAS-2B; red line, hiPSC-AECs; blue line, primary AECs. Error bars indicate SD. ap < 0.05 (BEAS-2B cells vs. hiPSC-AECs), #p < 0.05 (BEAS-2B cells vs. primary AECs).
Figure 4hiPSC-AECs attenuate Cd-induced cytotoxicity in BEAS-2B cells via paracrine effects. (a,b) All cells were cultured in the absence or presence (10 μM) Cd for 24 h. Cell lysates were extracted and subjected to Western blot analysis to determine protein levels of SFTPB. (c,d) Western blot analysis to determine protein levels of BCL-xl, IRE1α, and Bip/GRP78. (e,f) Transcript levels of inflammation-related (e) and apoptosis-related genes (f) in BEAS-2B cells exposed to Cd in the presence and absence of CM collected from hiPSC-AEC and primary AEC cultures. Full length blots are presented in Supplementary Fig. 2. Error bars indicate SD. *p < 0.05, **p < 0.01.
Figure 5Secretome analysis in CMs harvested from hiPSC-AEC, primary AEC and BEAS-2B cell cultures. Heat maps for secretions of BEAS-2B, hiPSC- and primary AECs. The color spectrum from green to red represents low to high expression (a). Venn diagram shows commonly up- (in bold) and downregulated (in bold italics) proteins in CMs of hiPSC- and primary AECs compared to CM of BEAS-2B (b). Expression levels of commonly up- and down-regulated 37 secretions in CMs of hiPSC- and primary AECs (c). Black dotted line indicates expression levels of genes in BEAS-2B cells.
Gene ontology (GO) analysis for secreting factors that commonly up- and downregulated in CMs of hiPSC- and primary AECs compared to CM of BEAS-2B cells.
| Term name | p-value | Secretions |
|---|---|---|
|
| ||
| Negative regulation of endopeptidase activity | 0.001416 | SERPING1, Hyaluronan-binding protein 2, Elafin, Serpin B5/Maspin |
| Cytokine-mediated signaling pathway | 0.001778 | PF4, EDA-A2, Ras, G-CSF R |
| Response to glucocorticoid | 0.006382 | Caspase-3, Ras, S-100b |
| Positive regulation of cell proliferation | 0.010178 | FGFR1 alpha, PTHLP, Ras, S-100b, Calreticulin/Vasotatin |
| Female pregnancy | 0.01169 | CD38, PTHLP, IGFBP-5 |
| Response to estradiol | 0.012196 | CD38, Calreticulin/Vasotatin, Caspase-3 |
| Positive regulation of gene expression | 0.012228 | PF4, EDA-A2, Calreticulin/Vasotatin, Ras |
| Platelet degranulation | 0.015432 | PF4, SERPING1, Coagulation factor XIII A |
| Striated muscle cell differentiation | 0.018313 | IGFBP-5, Ras |
| Positive regulation of NF-kappa B transcription factor activity | 0.024922 | EDA-A2, S100A8, Ras |
|
| ||
| Extracellular region | 3E-10 | PF4, RBP4, Hyaluronan-binding protein 2, FGFR1α, Calreticulin/Vasotatin, GPX3, Pro-Cathepsin B, Pancreatic Polypeptide, S100A8, Coagulation factor XIII A, CFHR2, EDA-A2, SERPING1, PTHLP, IGFBP-5, COCO, G-CSF R, S-100b |
| Extracellular space | 3E-07 | PF4, RBP4, Hyaluronan-binding protein 2, Calreticulin/Vasotatin, Pro-Cathepsin B, Pancreatic Polypeptide, GPX3, S100A8, TSLP, SERPING1, Serpin B5/Maspin, PTHLP, COCO, S-100b |
| Extracellular exosome | 3E-03 | Peptidase Inhibitor 16, NAIP, RBP4, Hyaluronan-binding protein 2, Elafin, Calreticulin/Vasotatin, Pro-Cathepsin B, GPX3, IRF6, S100A8, CD38, SERPING1, Serpin B5/Maspin |
| Platelet alpha granule lumen | 4E-03 | PF4, SERPING1, Coagulation factor XIII A |
|
| ||
| Signaling pathway | 0.01424 | GADD45A, Serpin B5/Maspin, Caspase-3 |
| Complement and coagulation cascades | 0.015061 | SERPING1, Hyaluronan-binding protein 2, Coagulation factor XIII A |
| Proteoglycans in cancer | 0.016442 | FGFR1α, Nanog, Caspase-3, Ras |
| Cytokine-cytokine receptor interaction | 0.023784 | PF4, EDA-A2, TSLP, G-CSF R |
| MAPK signaling pathway | 0.031078 | GADD45A, FGFR1α, Caspase-3, Ras |
Primer sequences used in quantitative real-time PCR.
| Gene | Sequence | |
|---|---|---|
|
| F | ATCAGTACCTCACGGCTGCT |
|
| F | CTGTCCTGCGTGTTGAAAGA |
|
| F | TACCCCCAGGAGAAGATTCC |
|
| F | GTGCAGTTTTGCCAAGGAGT |
|
| F | TGCTTGTCTGGAACAACTGC |
|
| F | AACCTCCTCTCTGCCATCAA |
|
| F | TGCTGTGACAACGACATCAAC |
|
| F | CAGATCCATTTTACGCTGATCCA |
|
| F | GAAAAAGAGCCGGTTGAAAAGC |
|
| F | GGAAACAGAGTGGTCATTCCC |
|
| F | TGCACCACCAACTGCTTAGC |
| R | GGCATGGACTGTGGTCATGAG |